Fisetin - NutraPedia

Back to Table of Contents

Fisetin: An Overview

1. Studied Conditions

Fisetin has been studied for a range of conditions, including but not limited to:

Age-related neurodegenerative diseases such as Alzheimer's and Parkinson's disease
Cancers, due to its potential anti-tumorigenic properties
Inflammatory disorders
Cardiovascular diseases
Diabetes, by potentially reducing blood sugar levels
Oxidative stress and associated disorders
Senescence, the process of cellular aging

2. Efficacy in Treating Conditions

Current research on fisetin is promising but still in the early stages. While laboratory and animal studies have shown some potential benefits, there is a lack of extensive clinical trials to conclusively determine its effectiveness in treating the aforementioned conditions in humans.

3. Health Benefits

Fisetin is believed to offer several health benefits, including:

Antioxidant activity, helping to neutralize harmful free radicals
Anti-inflammatory effects
Enhancing brain health and function
Potential to slow down aging processes
May improve longevity
Potential neuroprotective effects
May help in the prevention of certain cancers

4. Downsides

As with any supplement, fisetin may have downsides, including:

Potential side effects, which have not been thoroughly studied in humans
Interactions with other medications, which are not yet fully understood
Lack of regulation, as dietary supplements are not as strictly monitored as pharmaceuticals
Potential for overconsumption, especially since the optimal dosage for humans is not established

5. Genetic Variations

There is limited research on the interaction between fisetin and specific genetic variations. However, it is known that individual genetic makeup can affect the metabolism and effectiveness of various compounds. Therefore, fisetin may be more beneficial or harmful for people with certain genetic polymorphisms, but more research is needed to identify these variations and their impacts.

Research Summary on Fisetin

Fisetin and Cellular Aging: Studies have shown that fisetin, a flavonoid, decreases senescent cell markers in the brain and other organs in old sheep, suggesting its role in reducing cellular aging and potentially treating age-related diseases.

Neuroprotective Properties: Fisetin activates key signaling pathways in the brain, supporting long-term memory enhancement and neuroprotection, indicating potential benefits for memory disorders and neurodegenerative diseases.

Senolytic Potential: Fisetin is identified as a highly effective senotherapeutic compound, capable of selectively killing senescent cells in mice, improving health, and extending lifespan, with implications for human clinical studies.

Antioxidant and Anti-inflammatory Effects: The flavonoid modulates antioxidant enzyme levels and reduces inflammatory markers in several organs, showcasing its therapeutic potential against oxidative stress and inflammation.

Role in Bone Health: Fisetin has been seen to reduce bone density loss in mouse models of progeria, indicating its usefulness in addressing bone degeneration associated with aging.

Cancer Therapy: Research suggests a combined use of curcumin and flavonoids like fisetin and quercetin could serve as a potential anti-cancer therapy by inducing senescence in cancer cells and then selectively removing those cells.

Impact on Obesity: Fisetin inhibits key pathways involved in cell growth and lipid biosynthesis, contributing to reduced obesity in mice models.

Transition Metals and Neuroprotection: Fisetin's ability to chelate metals like iron and copper may enhance its neuroprotective effects in combating neurodegenerative diseases.

Fisetin Derivatives in Nerve Cell Development: Fisetin and related compounds support nerve cell growth and protection from oxidative stress through different mechanisms.

Enhancing Fisetin Bioavailability: Nanotechnology and structural modifications are being explored to improve fisetin's bioavailability for therapeutic use.

Senotherapeutic Strategies: Senolytics and senomorphics, including fisetin, target senescent cells to delay aging and treat age-related diseases, with clinical trials in progress.

Proteomic Analysis of Senescent Cells: Mass spectrometry-based proteomic technologies are critical for understanding the biology of senescent cells and developing targeted senotherapeutics.

Senolytics in Clinical Trials: Fisetin and other senolytics have entered clinical trials, showing potential in reducing senescent cell numbers and alleviating symptoms of age-related conditions.

Skin Rejuvenation: Fisetin effectively eliminates senescent skin cells, promoting skin rejuvenation by increasing collagen density and reducing inflammation.

References:

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!